Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages. 2012

Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
Leprosy Research Center, National Institute of Infectious Diseases, Higashimurayama, Tokyo, Japan.

Mycobacterium leprae (M. leprae) lives and replicates within macrophages in a foamy, lipid-laden phagosome. The lipids provide essential nutrition for the mycobacteria, and M. leprae infection modulates expression of important host proteins related to lipid metabolism. Thus, M. leprae infection increases the expression of adipophilin/adipose differentiation-related protein (ADRP) and decreases hormone-sensitive lipase (HSL), facilitating the accumulation and maintenance of lipid-rich environments suitable for the intracellular survival of M. leprae. HSL levels are not detectable in skin smear specimens taken from leprosy patients, but re-appear shortly after multidrug therapy (MDT). This study examined the effect of MDT components on host lipid metabolism in vitro, and the outcome of rifampicin, dapsone and clofazimine treatment on ADRP and HSL expression in THP-1 cells. Clofazimine attenuated the mRNA and protein levels of ADRP in M. leprae-infected cells, while those of HSL were increased. Rifampicin and dapsone did not show any significant effects on ADRP and HSL expression levels. A transient increase of interferon (IFN)-β and IFN-γ mRNA was also observed in cells infected with M. leprae and treated with clofazimine. Lipid droplets accumulated by M. leprae-infection were significantly decreased 48 h after clofazimine treatment. Such effects were not evident in cells without M. leprae infection. In clinical samples, ADRP expression was decreased and HSL expression was increased after treatment. These results suggest that clofazimine modulates lipid metabolism in M. leprae-infected macrophages by modulating the expression of ADRP and HSL. It also induces IFN production in M. leprae-infected cells. The resultant decrease in lipid accumulation, increase in lipolysis, and activation of innate immunity may be some of the key actions of clofazimine.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007917 Leprostatic Agents Substances that suppress Mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions. Antileprotic Agents,Leprostatics,Agents, Antileprotic,Agents, Leprostatic
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009166 Mycobacterium leprae A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
D011923 Rats, Nude A mutant strain of Rattus norvegicus without a thymus and with depressed or absent T-cell function. This strain of rats may have a small amount of hair at times, but then lose it. Athymic Rats,Nude Rats,Rats, Athymic,Athymic Rat,Nude Rat,Rat, Athymic,Rat, Nude
D002991 Clofazimine A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619) B-663,G-30,320,Lamprene,N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine,B 663,B663,G 30,320,G30,320
D003622 Dapsone A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) Diaminodiphenylsulfone,Sulfonyldianiline,4,4'-Diaminophenyl Sulfone,Avlosulfone,DADPS,Dapsoderm-X,Dapson-Fatol,Diaphenylsulfone,Disulone,Sulfona,4,4' Diaminophenyl Sulfone,Sulfone, 4,4'-Diaminophenyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
May 1987, Infection and immunity,
Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
December 2002, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
March 1981, Leprosy review,
Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
December 2008, FEMS microbiology letters,
Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
December 2011, Leprosy review,
Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
January 1988, Journal of leukocyte biology,
Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
August 1988, Infection and immunity,
Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
January 1971, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
January 2017, BioMed research international,
Yang Degang, and Takeshi Akama, and Takeshi Hara, and Kazunari Tanigawa, and Yuko Ishido, and Masaichi Gidoh, and Masahiko Makino, and Norihisa Ishii, and Koichi Suzuki
June 1984, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
Copied contents to your clipboard!